About Somalogic
Somalogic is a Healthcare company based in Boulder (United States) founded in 1999, and was acquired by Illumina in June 2025. Protein-based assays are developed for life science research. Somalogic has raised $663.99 million across 20 funding rounds from investors including Société Générale, Illumina and Mitsui & Co. The company has 319 employees. Somalogic has completed 1 acquisition, including Palamedrix. Its website somalogic.com draws about 16 thousand monthly visits. Somalogic offers products and services including SomaScan Assay, SomaScan Platform, and SomaSignal Tests. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Proteomics. Its legal entity is SomaLogic Operating Co., Inc. Its competitors include Nautilus Biotechnology, Amunix and Elektrofi; 3 of its 3 listed competitors have raised funding.
Company details
Somalogic was founded in 1999 and is based in Boulder, United States. Operations focus on the biotechnology sector, where proprietary SOMAmer reagentsprotein-binding molecules akin to aptamers and antibodiesare utilized in the SOMAscan assay for measuring multiple proteins. The platform is provided as reagents and kits to researchers. Future plans include laboratory-developed tests from a CLIA-certified lab and therapeutics derived from SOMAmer technology.
- Headquarters Boulder, United States
- Employees 319
- Stage Acquired
- SectorsHealthcare
- Website somalogic.com
- Social LinkedIn X Facebook
- Acquired by Illumina (Jun 2025)
- Legal Name Somalogic Operating Co., Inc.
- Annual Revenue$97.67 M (USD)20as on Dec 31, 2022
- Total Equity Funding$663.99M (USD)
in 20 rounds
- Latest Funding Round$211.97M (USD), Series E
Dec 2020
- InvestorsSociété Générale
& 26 more
- Employee Count319
- Investments & Acquisitions
- Acquired byIllumina
(Jun 2025)
Products & Services of Somalogic
Somalogic offers a comprehensive portfolio of products and services, including SomaScan Assay, SomaScan Platform, and SomaSignal Tests.
High-plex assay for measuring thousands of proteins from small samples.
Platform for discovery and validation in life sciences research.
Tests for identifying biomarkers in various diseases.
Funding Insights of Somalogic
Somalogic has successfully raised a total of $663.99M across 20 strategic funding rounds. The most recent funding activity was a Series E round of $211.97 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $663.99M
- Total Rounds 20
- Last Round Series E — $211.97M
- First Round $23M
(Nov 2000)
- Investors Count 26
Latest 10 of 20 funding rounds of Somalogic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | $211.97M | Series E | – | Janus Henderson Investors, Redmile Group | – |
| Nov 2020 | $121M | Series E | – | Casdin Capital | |
| Oct 2020 | $1M | Grant | – | – | |
| Jul 2018 | $200M | Series E | – | ICarbonX | |
| Feb 2018 | $429,021 | Grant | – | – | |
| Jan 2018 | $413,714 | Grant | – | – | |
| Jan 2017 | Series D | – | ICarbonX | – | |
| Mar 2016 | Debt – Conventional | – | – | ||
| Mar 2016 | Series D | – | Visium Asset Management | – | |
| Oct 2014 | $16.49M | Series C | – | Novartis | – |
27 investors in total: 27 institutional.
Investors in Somalogic
Somalogic has secured backing from 27 investors, including venture fund and institutional investors. Prominent investors backing the company include Société Générale, Illumina and Mitsui & Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are targeted for venture capital investments. | 1934 | janushenderson.com | London, United Kingdom | |
Private equity fund focused on the biotechnology sector | logoscapital.com | San Francisco, United States | ||
US-focused private equity and venture capital investments are managed. | bostonmillenniapartners.com | Boston, United States | ||
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Multiple investment strategies are pursued by this hedge fund. | 1986 | faralloncapital.com | San Francisco, United States | |
Multi-stage investment firm invests in healthcare and life sciences companies | foresitecapital.com | New York, United States | ||
A venture capital fund focused on tech and entertainment investments. | remagineventures.com | Tel Aviv, Israel | ||
| soleuscapital.com | ||||
Corporate backed venture capital firm investing in life sciences sector | nanfunglifesciences.com | San Francisco, United States | ||
| proquestvc.com |
Investor details for Somalogic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Somalogic
46 people are tracked at Somalogic (11 in leadership, 5 in board & advisors, 30 in team); the tracked headcount is 319.
| Name | Role | Group |
|---|---|---|
Omar Minshawi | Director, Strategic Accounts | Leadership |
Jen MacIntyre | Senior Director, Alliance Management | Leadership |
Tsuyoshi Karasawa | Director Strategic Accounts Life Sciences | Leadership |
Stephan Kraemer | VP Of Assay Development | Leadership |
Alison Roelke | Chief People Officer | Leadership |
Eliot Lurier | Interim CFO | Leadership |
Len Vanderbosch | Managing Senior Director, Key And Strategic Accounts | Leadership |
Jeff Buckthal | Associate Director, Life Sciences | Leadership |
Anna Mitchel | Director, Business Operations | Leadership |
Tala Khosroheidari | Senior Director Of Global Scientific Engagement | Leadership |
Micah Strom | Associate Director, Financial Planning & Analysis | Leadership |
Anne Margulies | Director | Board & advisors |
Richard Post | Director | Board & advisors |
Robert Barchi | Director | Board & advisors |
Kathy Hibbs | Director | Board & advisors |
Tycho Peterson | Director | Board & advisors |
Robert Walder | Scientist | Team |
Jenny Sayavong | Quality Control Analyst II | Team |
Breanna Smith | Scientist | Team |
Nancy Tran | Software Engineer | Team |
26 more people are available in the full profile.
Complete people profiles for Somalogic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Somalogic
Somalogic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Palamedrix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of a multi-omics platform for therapeutics and diagnostics | palamedrix.com | San Diego, United States | 2017 | Jul 2022 | $52.5M |
Complete acquisition details for Somalogic
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Somalogic
5 dated milestones of Somalogic across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Somalogic is founded.
- Funding First funding round of $23.0M.
- Funding Latest funding round, Series E, of $212.0M.
- Acquisition Acquires Palamedrix.
- Exit Acquired by Illumina.
Competitors of Somalogic
Somalogic has 3 listed competitors in our database, 3 of them funded. They include Nautilus Biotechnology, Amunix and Elektrofi.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| amunix.com | 2006 | Mountain View, United States | $200.59M | 82 | Peptide-based therapeutics are developed for cancers and immune disorders. | |
| elektrofi.com | 2016 | Boston, United States | $152.25M | 71 | Digital platform transforming the delivery of biologic medicines |
Detailed competitors of Somalogic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Somalogic
The website of Somalogic (somalogic.com) receives about 15.6K visits a month.
- Monthly visits15.6K
▲ 2.5% vs previous month
Websites whose visitors overlap most with Somalogic. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| decode.com | 100% | 13.6K | #1,966,785 | View details | |
quantics.co.uk | quantics.co.uk | 95% | #2,115,842 | – | |
| bioatla.com | 83% | 15.1K | #1,740,050 | View details | |
assignments.discoveryeducation.com | assignments.discoveryeducation.com | 51% | – | ||
australiangenomics.org.au | australiangenomics.org.au | 26% | #3,447,501 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Somalogic (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Somalogic
Complete news archive for Somalogic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Somalogic
Somalogic was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Somalogic is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Somalogic is a funded company, having raised a total of $663.99M across 20 funding rounds to date. The company's 1st funding round was a Series C of $16.49M, raised on Nov 2000.
Somalogic has 319 employees.
Annual revenue of Somalogic is $97.67M as on Dec 31, 2022.
Somalogic was founded in 1999 and is based in Boulder, United States. Operations focus on the biotechnology sector, where proprietary SOMAmer reagentsprotein-binding molecules akin to aptamers and antibodiesare utilized in the SOMAscan assay for measuring multiple proteins. The platform is provided as reagents and kits to researchers. Future plans include laboratory-developed tests from a CLIA-certified lab and therapeutics derived from SOMAmer technology.
Somalogic's top competitors include Nautilus Biotechnology, Elektrofi and Amunix.
Somalogic offers SomaScan Assay, SomaScan Platform, and SomaSignal Tests.
Somalogic has made 1 acquisition, including Palamedrix.
Somalogic has 27 investors. Key investors include Société Générale, Illumina, Mitsui & Co, Novartis, and Quest Diagnostics.
Somalogic operates through Somalogic Operating Co., Inc..
Yes. Somalogic was acquired by Illumina in June 2025.